Filtered By:
Source: Catheterization and Cardiovascular Interventions

This page shows you your search results in order of date. This is page number 4.

Order by Relevance | Date

Total 236 results found since Jan 2013.

Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta ‐analysis
ConclusionHCR appears to be safe, and has similar outcomes when compared with conventional CABG. HCR can be a suitable alternative to conventional CABG in select patients with MVCAD. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - May 4, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Partha Sardar, Amartya Kundu, Michelle Bischoff, Saurav Chatterjee, Theophilus Owan, Ramez Nairooz, Jay Giri, Michael E. Halkos, Henry Liberman, John S. Douglas, Debabrata Mukherjee Tags: Coronary Artery Disease Source Type: research

Impact of pre ‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following Transcatheter Aortic Valve Replacement: Results From The BRAVO 3 Randomized Trial
Conclusions: Prior or new‐onset AF within 30 days of transfemoral TAVR is noted in more than one‐third of patients. Despite greater baseline comorbidities than non‐AF patients, AF was not associated with greater risk of adjusted 30‐day outcomes. In the BRAVO 3 trial, early outcomes were similar regardless of anticoagulant strategy in each group. This article is protected by copyright. All rights reserved.
Source: Catheterization and Cardiovascular Interventions - May 1, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Christian Hengstenberg, Jaya Chandrasekhar, Samantha Sartori, Thierry Lefevre, Ghada Mikhail, Nicolas Meneveau, Christophe Tron, Raban Jeger, Christian Kupatt, Birgit Vogel, Serdar Farhan, Sabato Sorrentino, Madhav Sharma, Clayton Snyder, Oliver Husser, P Tags: VSD ‐ Valvular and Structural Heart Diseases Source Type: research

Comparison of antithrombotic agents during urgent percutaneous coronary intervention following thrombolytic therapy: A retrospective cohort study
ConclusionIn STEMI patients undergoing PCI within 24 hr after thrombolytic therapy, bivalirudin was associated with a strong trend toward reduced bleeding complications as compared to heparin alone or heparin plus GPI.The optimal antithrombotic regiment for urgent PCI following thrombolytic therapy is currently unknown. Our study demonstrated that use of bivalirudin during PCI following thrombolytic therapy is associated with a trend toward reduced bleeding complications compared to heparin alone or heparin plus GPI. Large randomized trials of adjunctive anticoagulation during PCI in this complex post‐thrombolytic popula...
Source: Catheterization and Cardiovascular Interventions - April 18, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Jaya R. Mallidi, Peter Robinson, Paul F. Visintainer, Amir S. Lotfi, Scott Mulvey, Gregory R. Giugliano Tags: Coronary Artery Disease Source Type: research

Transcatheter versus surgical aortic valve replacement in intermediate ‐risk patients: Evidence from a meta‐analysis
ConclusionsOur analysis of mid‐term results showed that TAVR has similar clinical efficacy to SAVR in intermediate‐risk patients with severe AS, and can be a suitable alternative to surgical valve replacement. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - April 11, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Partha Sardar, Amartya Kundu, Saurav Chatterjee, Dmitriy N. Feldman, Theophilus Owan, Nikolaos Kakouros, Ramez Nairooz, Linda A. Pape, Ted Feldman, J. Dawn Abbott, Sammy Elmariah Tags: Valvular and Structural Heart Diseases Source Type: research

Safety and efficacy of 6 ‐month versus 12‐month dual antiplatelet therapy in patients after implantation of multiple biodegradable polymer‐coated sirolimus‐eluting coronary stents: Insight from the I‐LOVE‐IT 2 trial
ConclusionsIn patients treated with multiple BP‐SES, 6‐ and 12‐month DAPT had similar impacts on 12‐month clinical outcomes. Additionally, 12‐month DAPT might reduce TLF between 6 and 12 months at the cost of a slightly increased risk of all bleeding events. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 19, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Jing Qi, Yi Li, Jing Li, Quanmin Jing, Kai Xu, Chuanyu Gao, Likun Ma, Zhi Zhang, Bo Xu, Yaling Han Tags: Coronary Artery Disease Source Type: research

Direct percutaneous transaxillary implantation of a novel self ‐expandable transcatheter heart valve for aortic stenosis
ConclusionsOur study suggests that the implantation of the second‐generation self‐expandable ACURATE Neo™ via a transaxillary access is technically feasible and safe and yields excellent short‐term clinical results. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 14, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Florian Deuschl, Niklas Schofer, Moritz Seiffert, Samer Hakmi, Isamu Mizote, Andreas Schaefer, Johannes Schirmer, Hermann Reichenspurner, Stefan Blankenberg, Lenard Conradi, Ulrich Sch äfer Tags: Valvular and Structural Heart Diseases Source Type: research

Impact of hospital volume on long ‐term neurological outcome in patients undergoing carotid artery stenting
ConclusionsCAS performed in high‐volume hospitals was associated with less new ischemic stroke after discharging from the index CAS, compared to those in low‐volume hospitals. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 14, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Chi ‐Sheng Hung, Chih‐Fan Yeh, Mao‐Shin Lin, Ying‐Hsien Chen, Ching‐Chang Huang, Hung‐Yuan Li, Hsien‐Li Kao Tags: Peripheral Vascular Disease Source Type: research

Outcome of implantation of a second self ‐expanding valve for the treatment of residual significant aortic regurgitation
ConclusionsSecond implantation of self‐expanding valve can successfully reduce residual significant AR following initial CV implantation and should be considered as therapeutic option for this population. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 14, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Edward Koifman, Nirav Patel, Gaby Weissman, Sarkis Kiramijyan, Romain Didier, Rebecca Torguson, Sandeep Kumar, Arpi Tavil ‐Shatelyan, Itsik Ben‐Dor, Lowell F. Satler, Augusto D. Pichard, Ron Waksman Tags: Valvular and Structural Heart Diseases Source Type: research

Percutaneous coronary intervention or coronary artery bypass grafting for unprotected left main coronary artery disease
ConclusionsIn patients with unprotected left main coronary disease and low to intermediate SYNTAX score, PCI might be an acceptable alternative to CABG. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 14, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Ahmed N. Mahmoud, Islam Y. Elgendy, Amgad Mentias, Marwan Saad, Walid Ibrahim, Mohammad K. Mojadidi, Ramez Nairooz, Parham Eshtehardi, R. David Anderson, Habib Samady Tags: Coronary Artery Disease Source Type: research

Right ventricular remodelling after transcatheter pulmonary valve implantation
ConclusionsEarly PPVI (<7 years after last RVOT operation) is associated with a more favorable RV reverse remodelling toward normal range and should be considered, before symptoms or RV damage become apparent. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 14, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Efstathios D. Pagourelias, Ana M Daraban, Razvan O Mada, J ürgen Duchenne, Oana Mirea, Bjorn Cools, Ruth Heying, Derize Boshoff, Jan Bogaert, Werner Budts, Marc Gewillig, Jens‐Uwe Voigt Tags: Pediatric and Congenital Heart Disease Source Type: research

A multicenter study of the impella device for mechanical support of the systemic circulation in pediatric and adolescent patients
ConclusionTemporary circulatory support with Impella devices is feasible in pediatric and adolescent patients, with acceptable risk profiles. More experience and follow up is needed to improve technical performance and patient selection. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - March 14, 2017 Category: Cardiovascular & Thoracic Surgery Authors: V. Vivian Dimas, Brian H Morray, Dennis W Kim, Christopher SD Almond, Shabana Shahanavaz, Sebastian C Tume, Lynn F Peng, Doff B McElhinney, Henri Justino Tags: Pediatric and Congenital Heart Disease Source Type: research

Good to great: TAVR tackles stroke risk
Key Points In this small feasibility trial of a next‐generation device, the TriGuardHDH embolic protection device (EPD) appears to be safe and feasible during use in the majority of the TAVR subjects studied. The question as to the use of EPD during TAVR, while intuitively appealing, is not further elucidated by the results of this small, uncontrolled study. Future research on this (and other) device(s) would be expected to include, at a minimum, a randomized arm, more standardized imaging, and neurological assessment (including longer‐term) protocols, and less variability in valve types used.
Source: Catheterization and Cardiovascular Interventions - February 20, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Justin Pelberg, William A. Gray Tags: Valvular and Structural Heart Diseases Source Type: research

End ‐stage renal disease and severe aortic stenosis: Does valve replacement improve one‐year outcomes?
ConclusionsPatients with ESRD and severe AS have a similar and higher survival with TAVR or SAVR when compared to BAV at 1‐year. These results may influence patient care decisions favoring valve replacement in AS patients with ESRD. © 2016 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 16, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Jose F. Condado, Aneel Maini, Bradley Leshnower, Vinod Thourani, Jessica Forcillo, Chandan Devireddy, Kreton Mavromatis, Eric L. Sarin, James Stewart, Robert Guyton, Amy Simone, Patricia Keegan, Stamatios Lerakis, Peter C. Block, Vasilis Babaliaros Tags: Valvular and Structural Heart Diseases Source Type: research

Manual thrombectomy efficiency in relationship to the area at risk in patients with myocardial infarction with TIMI 0 ‐1 coronary flow: Insights from an all comers registry
ConclusionIn comparison with the group where MT was inefficient, efficient MT may modestly reduce final infarct size without a significant clinical benefit. In comparison with PCI‐only, no difference was found regarding stroke. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 12, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Andr é Luz, Inês Silveira, Bruno Brochado, Patrícia Rodrigues, Maria João Sousa, Raquel Santos, Maria Trêpa, Mário Santos, João Silveira, Severo Torres, Adelino F. Leite‐Moreira, Henrique Carvalho Tags: Coronary Artery Disease Source Type: research

Thrombotic valvular dysfunction with transcatheter mitral interventions for postsurgical failures
ConclusionThrombotic related dysfunction post‐TMVR occurred in 15% (2/13) of patients and one patient had abnormal leaflet thickening that may have been thrombus related. Dual‐antiplatelet therapy was used in all 3 cases suggesting the possible need for oral anticoagulation postmitral valve‐in‐valve therapy. © 2017 Wiley Periodicals, Inc.
Source: Catheterization and Cardiovascular Interventions - February 9, 2017 Category: Cardiovascular & Thoracic Surgery Authors: Marvin H. Eng, Adam Greenbaum, Dee Dee Wang, Janet Wyman, DNP, Heider Arjomand, Pradeep Yadav, Hassan Nemeh, Gaetano Paone, Mayra Guerrero, William O'Neill Tags: Valvular and Structural Heart Diseases Source Type: research